Address
ValenzaBio
6701 Democracy Blvd Suite 300
Bethesda, MD 20817
United States
Website
VCID: 1051437
Profile
Corporate information
Official name
ValenzaBio Inc.
Registration country
Official name
ValenzaBio Inc.
Registration country
Investment activity status
Active investor
Company type
antibody for inflammatory eye diseaseOverview
ValenzaBio is a privately-held biopharmaceutical company developing therapies for autoimmune and inflammatory diseases. With a pipeline of differentiated monoclonal antibodies targeting clinically-validated mechanisms of action, we seek to provide improved therapies for patients with limited treatment options. Based in Bethesda, Maryland, in the heart of the capital biotech community, we strive to work collaboratively with all stakeholders while keeping our research and development efforts focused on the needs of patients.
Funding
Funding rounds
Series A USD 70,000,000
(8 Apr 2021) Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Fidelity Management and Research Co | investment management firm offering mutual funds, brokerage, retirement solutions, and asset management for institutions. | Initial investment. Led the round. | |
|
Ikarian Healthcare Fund LP | United States | Initial investment. Round participant. | |
|
Janus Henderson Group PLC | Global asset management group. | United Kingdom | Initial investment. Round participant. |
|
|
Opaleye LP | United States | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Fidelity Management and Research Co investment management firm offering mutual funds, brokerage, retirement solutions, and asset management for institutions. |
Series A | |
|
|
Ikarian Healthcare Fund LP |
214-276-0665 |
Series A |
|
|
Janus Henderson Group PLC Global asset management group. |
Series A | |
|
|
Opaleye LP |
617-229-5085 |
Series A |